Myriad Genetics, Inc.Myriad Genetics, Inc.Myriad Genetics, Inc.

Myriad Genetics, Inc.

No trades
See on Supercharts
Market capitalization
‪1.68 B‬USD
−3.20USD
‪−263.30 M‬USD
‪753.20 M‬USD
‪86.02 M‬
Beta (1Y)
2.50

About Myriad Genetics, Inc.

CEO
Paul J. Diaz
Website
Headquarters
Salt Lake City
Employees (FY)
‪2.7 K‬
Founded
1991
ISIN
US62855J1043
FIGI
BBG000D9H9F1
Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. It operates through the Diagnostics and Other segments. The Diagnostics segment provides testing and collaborative development of testing that is designed to assess an individual's risk of developing a disease later in life. The Other segment offers testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and also includes corporate services. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MYGN is 18.51 USD — it has decreased by 0.70% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Myriad Genetics, Inc. stocks are traded under the ticker MYGN.
Myriad Genetics, Inc. is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
MYGN stock is 3.82% volatile and has beta coefficient of 2.50. Check out the list of the most volatile stocks — is Myriad Genetics, Inc. there?
One year price forecast for Myriad Genetics, Inc. has a max estimate of 31.00 USD and a min estimate of 12.00 USD.
MYGN earnings for the last quarter are −0.03 USD whereas the estimation was −0.08 USD which accounts for 60.29% surprise. Estimated earnings for the next quarter are 0.01 USD. See more details about Myriad Genetics, Inc. earnings.
Myriad Genetics, Inc. revenue for the last quarter amounts to ‪191.90 M‬ USD despite the estimated figure of ‪182.32 M‬ USD. In the next quarter revenue is expected to reach ‪194.80 M‬ USD.
Yes, you can track Myriad Genetics, Inc. financials in yearly and quarterly reports right on TradingView.
MYGN stock has fallen by 9.22% compared to the previous week, the month change is a 14.78% fall, over the last year Myriad Genetics, Inc. has showed a 14.11% decrease.
MYGN net income for the last quarter is ‪−31.20 M‬ USD, while the quarter before that showed ‪−61.30 M‬ USD of net income which accounts for 49.10% change. Track more Myriad Genetics, Inc. financial stats to get the full picture.
Today Myriad Genetics, Inc. has the market capitalization of ‪1.68 B‬, it has increased by 1.70% over the last week.
No, MYGN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MYGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Myriad Genetics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
MYGN reached its all-time high on Nov 6, 2000 with the price of 65.80 USD, and its all-time low was 1.37 USD and was reached on Aug 31, 1998.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has ‪2.70 K‬ employees. See our rating of the largest employees — is Myriad Genetics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Myriad Genetics, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Myriad Genetics, Inc. stock shows the strong sell signal. See more of Myriad Genetics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Myriad Genetics, Inc. future price: according to them, MYGN price has a max estimate of 31.00 USD and a min estimate of 12.00 USD. Read a more detailed Myriad Genetics, Inc. forecast: see what analysts think of Myriad Genetics, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Myriad Genetics, Inc. EBITDA is ‪−75.10 M‬ USD, and current EBITDA margin is −9.48%. See more stats in Myriad Genetics, Inc. financial statements.